Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma

被引：2
|
作者：
Kumar, Vinay [1 ]
Shukla, Surendra Kumar [2 ]
机构：
[1] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Wexner Med Ctr, Columbus, OH 43210 USA
[2] OU Hlth Stephenson Canc Ctr, Dept Oncol Sci, Oklahoma City, OK 73104 USA
来源：
FRONTIERS IN MOLECULAR BIOSCIENCES | 2023年 / 10卷
关键词：
hepatocellular carcinoma (HCC); immunotherapy; metabolic alterations; gene network; HCC prognosis; liver cancer; CANCER;
D O I：
10.3389/fmolb.2023.1202614
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Bioinformatics analysis of molecular genetic targets and key pathways for hepatocellular carcinoma
    Tu, Junxue
    Chen, Jingjing
    He, Meimei
    Tong, Hongfei
    Liu, Haibin
    Zhou, Bin
    Liao, Yi
    Wang, Zhaohong
    ONCOTARGETS AND THERAPY, 2019, 12 : 5153 - 5162
  • [42] Pathways and targets in hepatocellular carcinoma
    Psyrri, Amanda
    Arkadopoulos, Nikolaos
    Vassilakopoulou, Maria
    Smyrniotis, Vassilios
    Dimitriadis, George
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1347 - 1357
  • [43] CHARACTERIZATION OF MOLECULAR AND SPATIAL DIVERSITY OF MACROPHAGES IN HEPATOCELLULAR CARCINOMA
    Hamon, Pauline
    Magen, Assaf
    Kim, Joel
    Buckup, Mark
    Troncoso, Leanna
    Hamel, Steven
    Le Berichel, Jessica
    Barboy, Oren
    David, Eyal
    Tabachnikova, Alexandra
    Chang, Christie
    Zhao, Zhen
    Cohen, Merav
    Giladi, Amir
    Malissen, Nausicaa
    Desland, Fiona
    Amit, Ido
    Kenigsberg, Ephraim
    Schwartz, Myron
    Marron, Thomas
    Merad, Miriam
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A713 - A713
  • [44] Genomic characterization of rare molecular subclasses of hepatocellular carcinoma
    Damrauer, Jeffrey S.
    Smith, Markia A.
    Walter, Vonn
    Thennavan, Aatish
    Mose, Lisle E.
    Selitsky, Sara R.
    Hoadley, Katherine A.
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [45] Genomic characterization of rare molecular subclasses of hepatocellular carcinoma
    Jeffrey S. Damrauer
    Markia A. Smith
    Vonn Walter
    Aatish Thennavan
    Lisle E. Mose
    Sara R. Selitsky
    Katherine A. Hoadley
    Communications Biology, 4
  • [46] An Integrated Molecular Characterization Correlates with the Progression of Hepatocellular Carcinoma
    Carrasco-Avino, G.
    Dudley, J. T.
    Ward, S. C.
    LABORATORY INVESTIGATION, 2014, 94 : 417A - 418A
  • [47] An Integrated Molecular Characterization Correlates with the Progression of Hepatocellular Carcinoma
    Carrasco-Avino, G.
    Dudley, J. T.
    Ward, S. C.
    MODERN PATHOLOGY, 2014, 27 : 417A - 418A
  • [48] Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis
    Wei, Junwei
    Ma, Luyuan
    Liu, Wenpeng
    Wang, Yadong
    Shen, Chuan
    Zhao, Xin
    Zhao, Caiyan
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 276
  • [49] Identification of putative molecular targets in Merkel cell carcinoma.
    Morgan, Sherif S.
    Feldman, Rebecca
    Cranmer, Lee D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Identification of Biological Targets of Therapeutic Intervention for Hepatocellular Carcinoma by Integrated Bioinformatical Analysis
    Hu, Wei Qi
    Wang, Wei
    Fang, Di Long
    Yin, Xue Feng
    MEDICAL SCIENCE MONITOR, 2018, 24 : 3450 - 3461
12345